parthenolide has been researched along with Benign Neoplasms, Brain in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, CM; Harki, DA; Hexum, JK; Kempema, AM; Largaespada, DA; Ohlfest, JR | 1 |
| Chai, Z; Li, J; Lu, L; Lu, W; Mao, J; Ran, D; Wu, S; Xie, C; Zhan, C; Zhang, Y; Zhou, J | 1 |
| Chen, Y; Li, P; Wang, S; Yu, Z; Yuan, Y; Zhou, G | 1 |
| Battastini, AM; Braganhol, E; Dalmolin, RJ; de Souza, LH; Gelain, DP; Moreira, JC; Pasquali, MA; Schröder, R; Zanotto-Filho, A | 1 |
| Anderson, KN; Bejcek, BE | 1 |
5 other study(ies) available for parthenolide and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Parthenolide prodrug LC-1 slows growth of intracranial glioma.
Topics: Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Glioma; Half-Life; Kaplan-Meier Estimate; Mice; Prodrugs; Sesquiterpenes | 2015 |
All-stage precisional glioma targeted therapy enabled by a well-designed D-peptide.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Endoplasmic Reticulum Chaperone BiP; Glioma; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Micelles; Paclitaxel; Peptides; Polyethylene Glycols; Rats, Sprague-Dawley; Sesquiterpenes; Temozolomide | 2020 |
Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cell Line, Tumor; DNA Modification Methylases; DNA Repair Enzymes; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Glioblastoma; Humans; Mice; Mice, SCID; Rats; RNA, Small Interfering; Sesquiterpenes; Signal Transduction; Temozolomide; Transcription Factor RelA; Treatment Outcome; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2018 |
NFκB inhibitors induce cell death in glioblastomas.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Astrocytes; Brain Neoplasms; Cell Cycle; Cell Death; Cell Line, Tumor; Cisplatin; Curcumin; Doxorubicin; Drug Synergism; Glioblastoma; Humans; Leupeptins; Molecular Targeted Therapy; NF-kappa B; Nitriles; Oxides; Rats; Sesquiterpenes; Signal Transduction; Sulfones | 2011 |
Parthenolide induces apoptosis in glioblastomas without affecting NF-kappaB.
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Caspase 3; Caspase 7; Cell Line, Tumor; Glioblastoma; Humans; NF-kappa B; Sesquiterpenes | 2008 |